Maximum quantity allowed is 999
请选择数量
CAS RN: 404950-80-7 | 产品编码: P3137
Panobinostat
×
![]()
×
纯度/分析方法: >93.0%(HPLC)
别名：
- 帕比司他
- (2E)-N-羟基-3-[4-[[[2-(2-甲基-1H-吲哚-3-基)乙基]氨基]甲基]苯基]-2-丙酰胺
- (E)-N-羟基-3-[4-[[[2-(2-甲基-1H-吲哚-3-基)乙基]氨基]甲基]苯基]丙酰胺
- (2E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide
- (E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]acrylamide
- LBH 589
产品文档：
| 规格 | 单价 | 同一天 | 2-3个工作日 | 左侧以上货期 | 数量 |
货期信息
|
|---|---|---|---|---|---|---|
| 10MG |
S$82.50
|
14 | 20 | 下单后约2周内可以发货 |
|
| 产品编码 | P3137 |
| 纯度/分析方法 | >93.0%(HPLC) |
| 分子式/分子量 | C__2__1H__2__3N__3O__2 = 349.43 |
| 外观与形状（20°C） | 固体 |
| 储存温度 | 冷藏 (0-10°C) |
| 储存在惰性气体下 | 存放于惰性气体之中 |
| 应避免的情况 | 空气,加热 |
| CAS RN | 404950-80-7 |
| Reaxys-RN | 12257756 |
| MDL编号 | MFCD09833242 |
技术规格
| Appearance | White to Light yellow to Light orange powder to crystal |
| Purity(HPLC) | min. 93.0 area% |
| NMR | confirm to structure |
物性（参考值）
| 熔点 | 115 °C |
GHS
| 象形图 |
|
| 信号词 | Danger |
| 危险性说明 | H301 : Toxic if swallowed. H361 : Suspected of damaging fertility or the unborn child. H370 : Causes damage to organs. H372 : Causes damage to organs through prolonged or repeated exposure. H341 : Suspected of causing genetic defects. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P260 : Do not breathe dust. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
相关法规
运输信息
| UN编号 | UN2811 |
| 类别 | 6.1 |
| 包装类别 | III |
| HS编码* | 2933.99-000 |
应用
Panobinostat (LBH589): A Histone Deacetylase (HDAC) Inhibitor
Histone deacetylases (HDACs) catalyze the removal of acetyl groups from the lysine residues of histones and some non-histone proteins and play important roles in maintaining chromatin structure and regulating gene expression, including tumor suppressor genes, and thus represent valid targets in the search for cancer therapeutics. Panobinostat (LBH589) has been reported to inhibit the enzymatic activity of HDACs implicated in cancer and has demonstrated potent anti-tumor activity. (The product is for research purpose only.)
References
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges (a review)
- Panobinostat Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors (a review)
- Panobinostat: First Global Approval (a review)
- Histone deacetylase inhibitors as anticancer drugs (a review)
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。